Gene expression profiling to identify druggable targets in prion diseases

Federico Benetti1, Lisa Gasperini, Mattia Zampieri

  • 1Laboratory of Prion Biology, Neurobiology Sector, Scuola Internazionale Superiore di Studi Avanzati-International School of Advanced Studies (SISSA-ISAS), Edificio Q1, Basovizza, Trieste, Italy.

Summary

Prion diseases remain challenging for drug discovery due to unknown molecular mechanisms. Transcriptome analysis offers insights into prion-induced changes, guiding future therapeutic strategies for neurodegeneration.